Nets guard Egor Demin sets NBA rookie record with a 3-pointer in 34th straight game

Brooklyn Nets guard Egor Demin made a 3-pointer in an NBA rookie-record 34th straight game on Friday night against the Utah ...

Golden State buries Utah 140-124 behind a flurry of 3-pointers

Stephen Curry scored 27 points, Moses Moody added 26 and the Golden State Warriors beat the Utah Jazz 140-124 on Wednesday ...
MIT Technology Review

Rules fail at the prompt, succeed at the boundary

Put rules at the capability boundary: Use policy engines, identity systems, and tool permissions to determine what the agent ...
The Hacker News

Critical vm2 Node.js Flaw Allows Sandbox Escape and Arbitrary Code Execution

A critical vm2 Node.js vulnerability (CVE-2026-22709, CVSS 9.8) allows sandbox escape via Promise handler bypass.

Quebec’s Mila institute raising $100-million fund for AI startups

The Mila artificial intelligence institute in Quebec is raising a US$100-million venture capital fund with plans to invest in more than 55 early-stage AI companies, in partnership with Inovia Capital ...
Yahoo Finance

Is Recursion Pharmaceuticals (RXRX) Pricing In Its AI Drug Discovery Ambitions?

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Wondering if Recursion ...
The Hacker News

Critical Node.js Vulnerability Can Cause Server Crashes via async_hooks Stack Overflow

Node.js released updates fixing a critical DoS flaw caused by async_hooks stack crashes, tracked as CVE-2025-59466, impacting most production apps.
Yahoo

Recursion Pharma's AI-powered therapy reduces colon growth in a rare disease trial

Dec 8 (Reuters) - Recursion Pharma, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in ...
Insider Monkey

Jim Cramer on Recursion: “It Is so Low That It Comes in Under the Category of Speculative”

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer discussed, along with the tech battleground. Answering a caller’s query about the stock during the lightning round, Cramer ...
STAT

Recursion’s incoming CEO: Beyond hype on AI-driven drug development, it’s time to show results

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
Seeking Alpha

Recursion Pharmaceuticals: What To Make Of This AI-Based Drug Discovery Leader?

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...
Forbes

Recursion’s Incoming CEO Needs To Prove That AI Drug Development Can Pay Off

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...